Table:
Focal segmental glomerulosclerosis	Proliferative LN(class III or IV)	Pure membranous LN (class V)
n of 10 (%)	Median (Range)	n of 7 (%)	Median (Range)	n of 7 (%)	Median (Range)
Females	3 (33%)	4/7 (57%)	5/7 (71%)
Race	Black	2/10 (20%)	3/7 (42%)	3/7 (42%)
White	5/10 (50%)	2/7 (29%)	2/7 (29%)
Other	3/10 (30%)*	2/7 (29%)†	3/7 (43%)**
Medications	Oral prednisone	4/10 (40%)	7/7 (100%)	4/7 (57%)
Mycophenolate mofetil	5/10 (50%)	3/7 (43%)	5/7 (71%)
Cyclophosphamide	-	2/7 (29%)	1/7 (14%)
Angiotensin blocking agent	9/10 (90%)	2/7 (29%)	6/7 (86%)
Kidney Status	GFR < 60 ml/min/m2	4/10 (40%)	1/7 (14%)	1/7 (14%)
Protein: creatinine ratio > 0.5	5/5 (100%)	7/7 (100%)	7/7 (100%)
Renal SDI score > 0¥	-	0/3	1/4 (25%)
Renal SLEDAI score‡	-	4 (0-16)	8 (4-12)
Presence of anti double-stranded-dsDNA	-	7/7 (100%)	4/7 (67%)

Express the table as Markdown code.

|  |  | <COLSPAN=2> Focal segmental glomerulosclerosis | <COLSPAN=2> Proliferative LN(class III or IV) | <COLSPAN=2> Pure membranous LN (class V) | 
 |  |  | n of 10 (%) | Median (Range) | n of 7 (%) | Median (Range) | n of 7 (%) | Median (Range) | 
 | --- | --- | --- | --- | --- | --- | --- | --- | 
 | Females |  | 3 (33%) |  | 4/7 (57%) |  | 5/7 (71%) |  | 
 | Race | Black | 2/10 (20%) |  | 3/7 (42%) |  | 3/7 (42%) |  | 
 |  | White | 5/10 (50%) |  | 2/7 (29%) |  | 2/7 (29%) |  | 
 |  | Other | 3/10 (30%)* |  | 2/7 (29%)† |  | 3/7 (43%)** |  | 
 | Medications | Oral prednisone | 4/10 (40%) |  | 7/7 (100%) |  | 4/7 (57%) |  | 
 |  | Mycophenolate mofetil | 5/10 (50%) |  | 3/7 (43%) |  | 5/7 (71%) |  | 
 |  | Cyclophosphamide | - |  | 2/7 (29%) |  | 1/7 (14%) |  | 
 |  | Angiotensin blocking agent | 9/10 (90%) |  | 2/7 (29%) |  | 6/7 (86%) |  | 
 | Kidney Status | GFR < 60 ml/min/m2 | 4/10 (40%) |  | 1/7 (14%) |  | 1/7 (14%) |  | 
 |  | Protein: creatinine ratio > 0.5 | 5/5 (100%) |  | 7/7 (100%) |  | 7/7 (100%) |  | 
 |  | Renal SDI score > 0¥ | - |  | 0/3 |  | 1/4 (25%) |  | 
 |  | Renal SLEDAI score‡ | - |  |  | 4 (0-16) |  | 8 (4-12) | 
 |  | Presence of anti double-stranded-dsDNA | - |  | 7/7 (100%) |  | 4/7 (67%) |  |